Merck & Co., Inc. Network Infrastructure Profile

Confidence

1

Public role: Profile subject linked to reviewed BTW article evidence.
Information type: This record preserves Merck & Co., Inc.'s organization identity while leaving legal entity, network resources, service scope, leadership, and related public sources open for enrichment.

Vioxx made cardiovascular signal handling a pharmaceutical-safety accountability test
Vioxx made cardiovascular signal handling a pharmaceutical-safety accountability test identifies Merck & Co., Inc. in relation to a named role, organisation, or operating context.
authorized human evidence

Last updated: 2026-08-27

Legal type:Private companyNot yet assessed

1

Vioxx made cardiovascular signal handling a pharmaceutical-safety accountability test
Rofecoxib offered meaningful gastrointestinal advantages over a traditional anti-inflammatory drug, yet its development and postmarket record also produced cardiovascular signals that were difficult to interpret and costly to leave unresolved. The Vioxx episode is an accountability test because the decisive question is not whether one result should have ended debate. It is whether the institutions with practical control converted uncertainty into timely trials, labeling, promotion limits, clinical communication, and independently verifiable drug-safety controls.
Primary articlePublished 2026-07-17